QQ客服 官方微博 反馈留言

	Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway.
	Yu Zhang; Liang Tao; Li-Xia Fan; Kun Huang; Hui-Min Luo; Hui Ge; Xiyan Wang; Qin Wang
刊名	Molecular medicine reports
	2019
ISSN号	1791-3004
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4605352
专题	湖南大学
作者单位	Department of Pharmacology, Zhongshan School of Medicine, Sun YatSen University, Guangzhou, Guangdong 510080, P.R. China. Tumor Research Institute, Xinjiang Medical University Affiliated Tumour Hospital, Urumqi, Xinjiang Uygur Autonomous Region 830000, P.R. China.
推荐引用方式 GB/T 7714	Yu Zhang,Liang Tao,Li-Xia Fan,et al. Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway.[J]. Molecular medicine reports,2019.
APA	Yu Zhang.,Liang Tao.,Li-Xia Fan.,Kun Huang.,Hui-Min Luo.,...&Qin Wang.(2019).Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway..Molecular medicine reports.
MLA	Yu Zhang,et al."Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway.".Molecular medicine reports (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。